Sitemap
Main Menu
Corporate Menu
- About Us
- Directors & Management
- Company Information
- Reports
- Announcements
- ASX Quarterly Reports - 30 June 2010
- ASX Appendix 3B with covering letter
- Transfer to NASDAQ Capital Market
- Extension of Quest license
- Appointment of Lewis Stuart
- BREVAGen data presented at ASCO 2010
- Patent claims upheld in full by USPTO
- EraGen Biosciences License
- Gen-Probe License
- Acquisition of BREVAGen
- Private placement of shares and ASX Appendix 3B
- GTG Investor Update - March 2010
- NASDAQ press release - 16 March 2010 Marketplace Rule 5810(b)
- Expiry of options - 2 March 2010
- ASX Appendix 4D - 31 December 2009 with Financial Report
- Assertion of property rights
- BioBusiness TV - GTG
- Lodgement of Appendix 4C
- Genetic Technologies Limited Broadcast
- Exclusive Distribution Agreement with Response Genetics, Inc.
- BREVAGen Option Agreement
- Lodgement of Appendix 3Z
- Lodgement of Appendix 3X
- Appointment of Mr. Tom Bonvino as Company Director
- Results from 2009 Annual General Meeting
- Resignation of Mr. Fred Bart as Chairman and Company Director
- Materials for 2009 Annual General Meeting
- Lodgement of Appendix 4C
- Shareholder Update
- Exclusive Distribution Agreement with Rosetta Genomics Inc.
- 2009 Annual Report and Notice of Annual General Meeting
- Appointment of Dr. Mal Brandon as Company Director
- Lodgement of Appendix 4E
- Genetic Technologies US Patent Update
- Withdrawal of German Nullification Action
- ImmunAid Project Update: Encouraging pilot results presented at ASCO
- Appointment of new Chief Executive Officer
- Expiry of Options
- Forfeiture of Options
- GTG Grants License to TIB MOLBIOL
- Lodgement of Appendix 3Z
- Resignation of Director
- New Position re BRCA Testing
- Lodgement of Appendix 3X
- Appointment Of New Directors
- Results from 2008 Annual General Meeting
- Lodgement of Appendix 3Y
- Intention To Appoint A Director
- Further Clarification On BRCA Testing
- Withdrawal Of Consent To Act As A Director
- 2008 Annual Report and Notice of Annual General Meeting
- GTG launches dog breed identification test
- Response to Notice of Intention to Move a Resolution
- Request for trading halt
- Preliminary Final Report
- Sale of exploration interest
- Genetic Technologies Clarifies Misconceptions on BRCA testing
- GTG acquires Frozen Puppies
- Genetic Technologies to enforce rights to BRCA patents
- Granting and cancellation of options
- Lodgement of Appendix 3Y
- GTG management update
- Appointment of Dr. Leanne Rowe AM to Board of Directors
- GTG awarded forensics outsourcing agreement by NSW Police
- GTG Licenses GE Healthcare
- Licensing Program Update
- Expiry and cancellation of options
- Results of 2007 Annual General Meeting
- Annual General Meeting Presentation
- Expiry and cancellation of options
- Lodgement of Appendix 3B
- 2007 Annual Report and Notice of Annual General Meeting
- Shareholder Information
- Corporate Governance
- Shareholder Meetings & List
- Licensing
- Research & IP
